Company intelligence / Profile preview

Sakura Finetek

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Sakura Finetek develops and manufactures automated instruments, consumables, reagents, and antibodies primarily for anatomic pathology laboratories. Their products are industry standards in tissue processing, embedding, staining, coverslipping, and digital imaging. The company does not develop therapeutics or conduct clinical trials but supports cancer diagnosis through advanced automation of laboratory workflows.

Therapeutic areas: OncologyOther
Modalities: DeviceReagentAntibodyProbe
Industry: Pathology

Partnerships

Historical partnerships with Miles-Sankyo Co.Medscand ABongoing collaborations with distributors/OEM partners globally

Beyond the preview

Go deeper on Sakura Finetek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sakura Finetek.

Explore the full profile